End Cash: The amount of cash held by the company for the given period.
Basilea Pharmaceutica AG (BPMUF) had End Cash of $195.94M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$303.84M |
|
$20.40M |
|
$35.02M |
|
$340.37M |
|
$59.40M |
|
$91.06M |
|
$112.40M |
|
$185.95M |
|
$154.43M |
|
$153.98M |
|
$154.43M |
|
-- |
|
| Cash Flow Statement Financials | |
$74.94M |
|
$-3.45M |
|
$-25.86M |
|
$150.34M |
|
|
End Cash |
$195.94M |
$45.60M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|